Covered recipient · General Payments record
REX A YANNIS
Allopathic & Osteopathic Physicians Ophthalmology Ophthalmic Plastic and Reconstructive Surgery
General Payments · PY2018–2024
$19,561.91
- Reported across 110 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $306.87 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $196.07 | 10 |
| Tarsus Pharmaceuticals, Inc. | $36.70 | 2 |
| ABBVIE INC. | $27.91 | 2 |
| Mallinckrodt Hospital Products Inc. | $24.53 | 1 |
| BIOTISSUE HOLDINGS INC. | $21.66 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $13.54 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106371732 | CMS |
| ABBVIE INC. | $14.37 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106371734 | CMS |
| Amgen Inc. | $7.17 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116217828 | CMS |
| Amgen Inc. | $6.47 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116217833 | CMS |
| Amgen Inc. | $8.98 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116217839 | CMS |
| Amgen Inc. | $124.98 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116217861 | CMS |
| Amgen Inc. | $7.48 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116217843 | CMS |
| Amgen Inc. | $6.83 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116217846 | CMS |
| Amgen Inc. | $3.71 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116217850 | CMS |
| Amgen Inc. | $0.78 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116217853 | CMS |
| Amgen Inc. | $23.17 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116217857 | CMS |
| Amgen Inc. | $6.50 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116217866 | CMS |
| BIOTISSUE HOLDINGS INC. | $21.66 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148769244 | CMS |
| Mallinckrodt Hospital Products Inc. | $24.53 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145154730 | CMS |
| Tarsus Pharmaceuticals, Inc. | $18.85 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139142512 | CMS |
| Tarsus Pharmaceuticals, Inc. | $17.85 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139142514 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.